Norway – Pharmaceutical products – Framework agreement for medicinal products and multi-doses for Sogndal
Description
Background and purpose Sogndal municipality wishes to enter into a framework agreement for the delivery of medicines, multi-dose and pharmacy products for the village of Sogndal. Bygdene Leikanger and Balestrand are all involved in a framework agreement through the INSS procurement cooperation. Medicine for a heimebuande vert dekka av brukaren sjølv and is not a part of the economic ramma of the agreement. The costs involved in packing a multi-dose to a home-bound host paid for by the municipality. The framework agreement does not cover medical consumables, as the municipality has a framework agreement for this. Description of customer The contract is for Sogndal in Sogndal municipality. All references to "Sogndal" debts the village of Sogndal, not the municipality as cheering. Sogndal has approx. 9,000 inhabitants. Sogndal has approx. 46 heildøgnsplassar institution, 300 user of heimeteneste, 260 heimebuande, which has medicine administered by the municipality, 165 uses with multidose.
Codes CPV
Documents et soumission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Marchés similaires
Norway – Pharmaceutical products – Medicines and multi-dose Narvik kommune - Framework agreement
Harstad KommuneNorvègePharmaceutical productsMedicinal products for dermatology and the musculo-skeletal systemPharmaceutical articlesDélai dans 26 joursPublié le 03 nov. 2026
Norway – Medical equipments – Linac to Sørlandet Hospital
SYKEHUSINNKJØP HFNorvègeMedical equipmentsLinear acceleratorsAucune date limite donnéePublié le 03 nov. 2026
Norway – Medical equipments – Copy of PCR instrument
SYKEHUSINNKJØP HFNorvègeMedical equipmentsDélai dans 30 joursPublié le 03 nov. 2026
Norway – Sterilisation, disinfection and hygiene devices – Low temperature steriliser for the sterile centre in Helse Bergen.
SYKEHUSINNKJØP HFNorvègeSterilisation, disinfection and hygiene devicesDélai dans 33 joursPublié le 03 nov. 2026